Oct 30, 2023 | Glass Pharms
PRESS RELEASE Monday October 30th For immediate release 1st November this year marks five years since the UK government legalised cannabis-based products for medicinal use in 2018 and figures released by the Home Office this week have shown that the amount of...
Jan 18, 2023 | Glass Pharms
Glass Pharms are supporting a Health Economics Analysis study conducted by the University of York that will examine the potential economic cost benefits if cannabis-based medicines were prescribed to chronic pain patients on the NHS. The research will include a...
Sep 21, 2022 | Glass Pharms
LONDON, Sept. 21, 2022 /PRNewswire/ — Having secured up to £26.7M of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis cultivation company, are delighted to announce a team of best-of-breed partners to complete their...
